No—clarithromycin and simvastatin should not be taken together. The FDA classifies this combination as contraindicated, meaning the risks outweigh any potential benefits. Clarithromycin significantly increases simvastatin levels in the blood by blocking the enzyme that breaks it down, creating a dangerous buildup that can cause severe muscle damage and kidney injury. If you are currently taking both medications, contact your doctor or pharmacist immediately to discuss alternatives.
The FDA labeling for clarithromycin explicitly lists simvastatin as a contraindicated drug. The agency's warning states that "Clarithromycin may increase the exposure of [simvastatin] by inhibition of CYP3A metabolism, thereby increasing the risk of toxicities from these drugs." This language places simvastatin in the same dangerous category as lovastatin and lomitapide—medications with the highest interaction risk.
The contraindication is not a cautionary recommendation or suggestion to monitor closely. It is an absolute prohibition. Other statins in the same family—atorvastatin, pravastatin, and fluvastatin—carry a "use with caution" warning, which is significantly less severe. The fact that simvastatin gets the harshest classification tells you how serious this interaction is.
To understand why clarithromycin and simvastatin cannot be safely combined, you need to know how your body eliminates simvastatin. Simvastatin is metabolized primarily by an enzyme called cytochrome P450 3A4 (CYP3A4), which sits in your liver and intestinal wall. This enzyme acts as a "chemical gatekeeper"—it breaks down simvastatin into inactive metabolites that your body can then eliminate through bile and urine.
Clarithromycin is a macrolide antibiotic, a class of drugs known for potently inhibiting CYP3A4. When you take clarithromycin, it binds to CYP3A4 and essentially shuts down the enzyme's ability to process other drugs. With simvastatin, this creates a critical problem: the drug cannot be metabolized efficiently, so it accumulates in your bloodstream to much higher levels than intended.
Studies have shown that clarithromycin can increase simvastatin blood levels by 5- to 10-fold or more, depending on the dose and individual factors. This astronomical increase in drug exposure is what triggers the dangerous side effects described below.
At normal doses, simvastatin works by inhibiting HMG-CoA reductase, an enzyme crucial for cholesterol synthesis. The drug is generally well tolerated because the dosing is calibrated to achieve therapeutic cholesterol-lowering effects at safe concentrations. But when clarithromycin prevents simvastatin from being eliminated, the drug accumulates to concentrations far above those studied in clinical trials. At these elevated levels, simvastatin's effects become toxic.
While anyone taking both medications faces increased risk, several patient populations are especially vulnerable to severe complications:
A 72-year-old male with a history of myocardial infarction is on simvastatin 40 mg daily as part of his secondary prevention regimen. His other medications include lisinopril for hypertension and aspirin. He develops a community-acquired respiratory infection with signs and symptoms suggestive of bacterial pneumonia. His primary care physician prescribes clarithromycin 500 mg twice daily for 7 days without reviewing the full medication list carefully.
By day 3 of clarithromycin therapy, the patient develops severe muscle pain (myalgia) in both thighs and calves. He attributes it to overuse and continues taking both medications. By day 5, he notices dark urine and reduced urine output—signs of acute kidney injury from muscle breakdown products (myoglobin) overwhelming the kidneys. He is admitted to the hospital, where laboratory tests reveal:
He is diagnosed with statin-induced rhabdomyolysis. Treatment requires discontinuation of both simvastatin and clarithromycin, aggressive IV hydration, and intensive monitoring. His kidney function gradually recovers over 10 days, but the experience was serious and avoidable.
The lesson: Even in an older adult on a moderate simvastatin dose, the combination caused severe muscle toxicity. The contraindication exists for exactly this reason.
A 58-year-old woman with hyperlipidemia is on simvastatin 20 mg nightly. She develops sinusitis with bacterial culture showing susceptibility to macrolides. Her pharmacist reviews her medication profile and flags the clarithromycin–simvastatin contraindication before the prescription is filled.
The pharmacist contacts her physician with three options:
The physician chooses option 2, prescribing amoxicillin-clavulanate instead. The patient's sinusitis resolves without incident, and she continues simvastatin without any change to her management. This approach demonstrates how recognizing the contraindication early prevents harm.
If you are currently taking both drugs: Do not stop either medication abruptly. Contact your doctor or pharmacist within 24 hours. Stopping simvastatin suddenly can cause rebound hypercholesterolemia; stopping clarithromycin early may allow the infection to return. Your healthcare provider will create a safe transition plan.
If clarithromycin is being prescribed to you: Inform your doctor or pharmacist immediately that you take simvastatin. Provide a complete list of all medications, including over-the-counter drugs and supplements. Do not fill the prescription until the interaction has been addressed.
Safe alternatives to clarithromycin: Depending on the infection type, azithromycin is a macrolide antibiotic with less potent CYP3A4 inhibition (though caution is still warranted). Fluoroquinolones (levofloxacin, moxifloxacin), beta-lactams (amoxicillin, cephalosporins), or doxycycline are often suitable alternatives that do not interact with simvastatin.
If you must take clarithromycin: Ask your doctor about temporarily switching to a statin with lower CYP3A4 dependence, such as pravastatin, rosuvastatin, or fluvastatin. This swap is reversible and carries minimal clinical risk for short antibiotic courses.
Seek immediate medical attention if you experience any of the following while taking clarithromycin and simvastatin (or shortly after starting clarithromycin):
Call your pharmacist or doctor before your next dose if you notice muscle soreness that is mild but new, or if you have questions about whether your other medications interact with clarithromycin.
For more information on related drug interactions, you may also want to review:
Drug interactions are most dangerous when they go undetected. If you take simvastatin—or any statin—alongside antibiotics, blood pressure medications, antifungals, or other commonly prescribed drugs, you owe it to yourself to verify there are no hidden interactions. Visit checkdruginteractions.com and enter your complete medication list (including over-the-counter drugs and supplements) to run a comprehensive interaction check. Our database contains over 250,000 FDA drug labels and is updated continuously with the latest safety data. A few minutes now could prevent a serious medical emergency.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Methotrexate and ibuprofen have a major FDA-documented interaction. Learn mechanism, monitoring, and safe management strategies for healt...
Tacrolimus and fluconazole interaction explained. Learn severity, risks, and what FDA labels say about combining these drugs.
Is it safe to take methimazole and warfarin together? Learn about this drug interaction from FDA data and pharmacology.